New biological marker of early-stage Alzheimer's disease uncovered

Researchers have identified a new biological marker that can detect early-stage Alzheimer's disease, potentially allowing for earlier diagnosis and intervention. Alzheimer's disease is a progressive neurodegenerative disorder characterized by memory loss and cognitive decline, caused by abnormal buildup of amyloid and tau proteins that damage neurons and their connections. This breakthrough discovery could enable doctors to identify the disease before symptoms become severe, offering patients a better window for treatment options. Early detection is crucial as interventions administered in the disease's initial stages may help slow progression and preserve cognitive function longer. This advancement represents a significant step forward in the fight against Alzheimer's, one of the leading causes of dementia affecting millions worldwide.